- Major global public health events (outbreaks of infectious diseases)
- National policy for centralized procurement (reducing profit margins of generic drugs)
- Geopolitical risks (sanctions, restrictions on technology introduction and international strategic cooperation)
Sino Biopharmaceutical Limited
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Sino Biopharmaceutical Limited disclosed greenhouse gas emissions of 239.2K tCO2e/year. By scope: Scope 1: 17.0K tCO2e/year; Scope 2: 222.2K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
239.2K tCO2e/year
2023
Renewable Energy
7,504.19 MWh representing 76.64% increase from 2022
of total energy
Water Usage
3.0M m3/year
2023
Waste
7.6K tons/year (hazardous) and 3602.59 tons/year (non-hazardous)
2023
Energy Use
479.1K MWh/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 17.0K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 222.2K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- 13% reduction in GHG emission density compared to the benchmark year (2021)
- 76.64% surge in clean energy consumption from the previous year
- 5% decrease in packaging material consumption compared to the previous year
- Completed carbon inventories of two pilot units and identified emission reduction opportunities
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce GHG emissions per RMB1 million of revenue by 20% by 2025 (with 2021 as the benchmark year)
- Reduce hazardous waste discharges per RMB1 million of revenue by 10% by 2025 (with 2021 as the benchmark year)
🌱 ESG Focus Areas
CureAccessibleRelationshipEnvironmental